- Knowledge center
Roel Sterken joined Biogazelle in June 2019 to strengthen the management team, and has taken the role of CEO since December 2020. Prior to joining Biogazelle, Roel was a Sr. Strategy and Business consultant for Janssen Pharmaceuticals and Investment Manager at DROIA Oncology Ventures, carrying different managerial and board level responsibilities. Roel holds a PhD in Molecular Biotechnology from VIB-Ghent University and an MBA degree from Solvay Brussels School of Economics and Management.
Jan Hellemans is one of the founders of Biogazelle. Jan has a Master's degree in Biotechnology, a PhD in Medical Sciences (Ghent University, Belgium) and over 15 years of experience in human genetics. He acquired extensive experience in next generation sequencing and genetic diagnostics from managing an academic core facility and introducing the corresponding wet and dry lab technology in a clinical diagnostics lab at Ghent University Hospital.
Jo Vandesompele has a Master's degree in Bio-engineering and a PhD in Medical Sciences. As Chief Scientific Officer, he is responsible for the scientific progress in the company. Jo also holds a professorship at Ghent University, studying non-coding RNA biology in cancer and developing nucleic acid quantification strategies. He is co-author of more than 200 peer-reviewed articles, together cited more than 30,000 times.